Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China · Delayed Price · Currency is CNY 47.65
-0.96 (-1.97%)
Aug 21, 2026, 3:00 PM CST
SHA:688336 Market Cap
SHA:688336 has a market cap or net worth of 42.71 billion as of August 21, 2026. Its market cap has increased by 28.62% in one year.
Market Cap
42.71B
Enterprise Value
41.48B
Revenue
4.42B
Ranking
n/a
PE Ratio
14.02
Stock Price
47.65
ChartMarket Cap Chart
Since July 22, 2020, SHA:688336's market cap has increased from 33.34B to 42.71B, an increase of 28.10%. That is a compound annual growth rate of 4.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 42.71B | 16.23% |
| Dec 31, 2025 | 36.74B | 178.10% |
| Dec 31, 2024 | 13.21B | -4.84% |
| Dec 29, 2023 | 13.88B | 77.24% |
| Dec 30, 2022 | 7.83B | -31.47% |
| Dec 31, 2021 | 11.43B | -24.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haisco Pharmaceutical Group | 74.56B |
| Asymchem Laboratories (Tianjin) | 63.54B |
| Shanghai Allist Pharmaceuticals | 54.35B |
| Suzhou Zelgen Biopharmaceuticals | 36.62B |
| Beijing Wantai Biological Pharmacy Enterprise | 35.42B |
| Shanghai RAAS Blood Products | 32.24B |
| Chongqing Zhifei Biological Products | 28.89B |
| Xiamen Amoytop Biotech | 26.29B |